Non-Invasive Prenatal Testing
VerifiTM Prenatal Testing
The VerifiTM Prenatal Test safely and noninvasively screens for the most common chromosomal aneuploidies as early as 10 weeks gestation using a single maternal blood draw, offering the lowest test failure rate in the industry. The Verifi Prenatal Test uses sequencing technology to provide accurate information for pregnant women regardless of age or risk.
| VerifiTM | |
| Total Cases | 86,000 |
| Average Turnaround Time | 3.3 business days |
| Technical Cancellations | 0.1 % |
| Aneuploidy Detected | 2.2 % |
| Observed False Positives | 0.12 % |
| Observed False Negatives | 0.02 % |
Why choose the VerifiTM Test?
- Comprehensive portfolio with expanded panel available
- Fast turnaround time
- Lowest published failure rate in the industry, 0.1%
- Proven superiority to traditional screening methods for the screening of common fetal aneuploidies, with reduced false positive rates (increased specificity) and increased positive predictive values (PPV)
Standard VerifiTM Test
| Trisomy 21 | Down syndrome |
| Trisomy 18 | Edwards syndrome |
| Trisomy 13 | Patau syndrome |
| Monosomy X(X0) | MX/Turner syndrome |
| XXY | Klinefelter syndrome |
| XXX | Triple X |
| XYY | Jacob’s syndrome |
| Microdeletion | Disease |
| 1p36 | 1p36 deletion syndrome |
| 4p | Wolf-Hirschhorn syndrome |
| 5p | Cri du chat syndrome, |
| 15q11.2(pat) | Prader-Willi syndrome |
| 15q11.2(mat) | Angelman syndrome |
| 22q11.2 | DiGeorge syndrome |
VerifiTM Plus 1
Standard VerifiTM + all chromosome
VerifiTM Plus 2
Standard VerifiTM + microdeletion
VerifiTM Plus 3
Standard VerifiTM + all chromosome + microdeletion
How the Process Works
- Physician recommends and orders test for patient.
- Requisition and Informed Consent forms are completed, patient proceeds to blood draw.
- Blood sample and test request form are sent back to lab.
- Lab processes and analyzes the sample.
- Test results are sent to health care professional.
